Quarterly report · Q3
6095.TEDINET S100OXHE
Period2021-10-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.4bn | 2021-10-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥7.4bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥907m | 2021-10-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥655m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥943m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥651m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥969m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥9.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥8.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2021-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥30.33 | 2021-10-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.59 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.07 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.82 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.02 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.76 | 2021-10-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.25 | 2020-10-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.12 | 2020-10-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 80.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥518m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥8m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥100m |
| —segment total | revenue | 2021-10-01 → 2022-06-30 | ¥6.5bn |
| —segment total | revenue external | 2021-10-01 → 2022-06-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥12m |
| —segment total | segment profit | 2021-10-01 → 2022-06-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥357m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥5m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥396,000 |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥196m |
| —segment total | revenue | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue external | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥6m |
| —segment total | segment profit | 2020-10-01 → 2021-06-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 329
| Item | Context | Value | Unit |
|---|---|---|---|
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)１単元の株式数は100株であります。 | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)メドピア株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都中央区築地一丁目13番１号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentQuarterDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |